Member Info for RichMacintyre

Stop it now, behave! meta own the hardware, they are investing in equipment. Capai want to RESELL the likes of chatgpt and hope people pay a premium to have a fancy website in the way. Price of tokens is going up and this outfit have to pay. This is a joke, they own nothing, anyone with half a brain will go directly to the likes of meta.

Leaky?

“Our delivery platform looks better than approved ADC drugs in preclinical/comparative models, and our dual-payload version is showing stronger tumour control than single-payload approaches.”

That is exciting, but still needs human proof.

Sounds about right, how much will that cost. I told you not to invest in this and I was right. come back in a year and maybe worth investing.

Oh behave yourself mornington! you ramp this share knowing its dead, they missed the AI bubble and now trying to white label other models.

Great update, 5-6mio in the bank will last 12 months. I was right to move most of my money in here, I still like Faron but they have a few months yet before they make any serious moves.

This was clearly the wrong stock so why on earth so many people liked my post is beyond me. 5-6mio would not last 12 moths here, I have no investment here.

Great update, 5-6mio in the bank will last 12 months. I was right to move most of my money in here, I still like Faron but they have a few months yet before they make any serious moves.

Oh behave, Hemogenyx will be bought out long before that pumped up Avacta ever gets bought, I have been around the city long enough to recognise the desperation when a company puts out an RNS to announce being mentioned in a magazine or attending a conference. SAD.

I added again yesterday when it appeared the distressed seller had finished, positive news flow in Hemogenyx has the sleeping giant potential I just do not see elsewhere. I have fully exited my Faron position having made a decent return, it will have its time in the sun again but pharma works in cycles, you must learn to read them! Follow me and you wont go far wrong, I shall try and engage more when time permits.

I had previously indicated that the share price was unlikely to decline significantly below 45p. The entry point was executed as anticipated, and we are now observing the expected recovery.

The current market capitalisation of approximately £70 million appears undervalued, as it does not yet reflect the anticipated £40 million capital injection. This positions the company as attractively valued relative to its upcoming financial position.

I continue to see multiple investment opportunities in the stock over the coming year, particularly as clinical trials advance. The strengthened cash position provides a solid foundation and de-risks the business in the near term.

While I have trimmed the position to capitalise on other attractive opportunities in the portfolio, I intend to maintain a modest holding given the company’s robust balance sheet and secure financial runway.

Like all wise fools I took the day off yesterday so I was not here to point out the obvious. The 30% rise yesterday is nothing more than a dead cat bounce. There may have been a place for CapAI as an early mover but now I am afraid a Pro subscription for Claude will give you everything this cowboy outfit is offering. Do not get burned here, this company has nothing novel to offer.

An ISA is limited to 20K, look into a Family Investment Company if you have a larger holding here or indeed elsewhere, but move quickly, I had a chance to speak to a company advisor and there will be an update soon on the trial and other news. I told you once funding is resolved at Faron the share price would start to recover, I am slowly reducing my exposure there and adding here for the obvious near term potential. I will go back to Faron later in the year as the trial progresses.

Thank you, hopefully it takes at least a week, I expect Faron to bounce hard once the 40mio is confirmed, I will be selling on the bounce to load here before the trials resume.

Ah, that is excellent news, thank you both, advised my partner that all FDA submissions had a 28 day waiting period which was met with disappointment. We view this transfer as a critical de-risking point but its patient data that matters. Did he give you any indication of when the next patient would be treated?

I agree with your assessment, there is nothing special about CapAI, it was never more than a wrapper and sadly for this company a wrapper is no longer required, they paid for tokens at a loss funded by shareholders.

I was alarmed this morning seeing such a large drop and made a few calls, Hemogneyx was my second highest investment after Faron, I was holding cash aside to take up my offer but that is looking unlikely at this point. Took advice from the broker that they are aware of no material reason for the selling and things are progressing well. I have put that money in here, but I remain bullish on Faron post 27th when the open offer closes.

Oh behave! Enough of this nonsense.

AI has been asked to hack governments and rewrite firmware drivers and done so independently. I produced a pretty excellent childrens story with only a few paragraphs of prompt and its fully illustrated. It was the free LLM. If CapAI had delivered what they promised immediately they may have had first mover advantage, now? Pick Claude Haiku if you want to write a novel and its done. No serious person who has used an AI in the past few months would consider investing in CapAI, just stop your nonsense. AI does not need wrappers any more.

As I said, the SP will be held until the action is done, the city will not want private investors taking part when they have underwritten the entire offering. Price should recover significantly once the threat of PI RI uptake is gone.

Behave yourself. Its a reverse CLN, instead of giving more shares for the same amount of money they get less money for the same amount of shares with no floor. Says quite clearly they need 8p, but Lanstead would have to stop selling to achieve that.

They will sell non stop and at the end of the month the calculated figure will be the vwap lowest price deciding how much money to give to IMM, it wont be 6m when this is finished 2-3 mio if lucky and with 500k being administrative fees associated with the fund raise?

Atleast they offered a retail offer at 6p so if anyone feels charitable they can donate to the company

Nothing this company is working on is going to catch up to what is already freely available out there, they were once selling themselves as a wrapper, not required any more as voice mode, native language now gives excellent results across the board.

The funding is underwritten by those who want the stock at 50c, its being offered to us on same terms to make it palatable. The share price will be supressed around this area to limit PI uptake. There will be strong recovery once this is done.